Hosted on MSN10mon
FDA approves BeiGene’s TEVIMBRA for oesophageal cancer
BeiGene solid tumours chief medical officer Mark Lanasa stated: “The FDA approval of TEVIMBRA for patients with ESCC who have previously received chemotherapy, along with its ongoing review of ...
PMLiVE1mon
BeiGene’s Tevimbra combination granted FDA approval to treat gastric cancer
Mark Lanasa, chief medical officer, solid tumours at BeiGene, said: “This is the second US approval for Tevimbra [in 2024], underscoring its potential to address critical needs in oncology.” The ...